1. Home
  2. KRO vs JANX Comparison

KRO vs JANX Comparison

Compare KRO & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kronos Worldwide Inc

KRO

Kronos Worldwide Inc

HOLD

Current Price

$8.18

Market Cap

1.0B

Sector

Industrials

ML Signal

HOLD

Logo Janux Therapeutics Inc.

JANX

Janux Therapeutics Inc.

HOLD

Current Price

$16.44

Market Cap

975.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRO
JANX
Founded
1916
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
975.7M
IPO Year
2004
2021

Fundamental Metrics

Financial Performance
Metric
KRO
JANX
Price
$8.18
$16.44
Analyst Decision
Strong Sell
Buy
Analyst Count
2
13
Target Price
$6.00
$47.00
AVG Volume (30 Days)
325.7K
813.7K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
2.79%
N/A
EPS Growth
N/A
N/A
EPS
0.09
N/A
Revenue
$1,859,400,000.00
$10,000,000.00
Revenue This Year
$6.75
N/A
Revenue Next Year
$8.36
N/A
P/E Ratio
$90.44
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.08
$12.12
52 Week High
$9.17
$35.34

Technical Indicators

Market Signals
Indicator
KRO
JANX
Relative Strength Index (RSI) 48.28 45.63
Support Level $5.97 $13.00
Resistance Level $9.03 $19.14
Average True Range (ATR) 0.39 0.77
MACD -0.13 -0.27
Stochastic Oscillator 11.11 7.98

Price Performance

Historical Comparison
KRO
JANX

About KRO Kronos Worldwide Inc

Kronos Worldwide Inc manufactures and sells titanium dioxide pigments. Titanium dioxide is a white inorganic pigment used in various products. The majority of Kronos' sales come from titanium dioxide used for coatings on automobiles, aircraft, machines, appliances, traffic paint, and in both commercial and residential interiors and exteriors. The second product category is titanium dioxide used for plastics such as packaging materials and food packaging, houseware, appliances, toys, and computer cases. The maximum of revenue comes from the United States.

About JANX Janux Therapeutics Inc.

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. The proprietary technology of the company has enabled the development of distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr), Tumor Activated Immunomodulators (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms. The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.

Share on Social Networks: